Reducing fatigue in Long COVID-19: A feasibility study of a self-help intervention to reduce fatigue-related symptoms among patients in general practice
Not Applicable
- Conditions
- Fatigue symptoms following Long COVIDInfections and Infestations
- Registration Number
- ISRCTN99840264
- Lead Sponsor
- orthern Care Alliance
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
1. Adult aged 18 years or over
2. Tested positive for COVID (between July 2020 and February 2022)
3. Scored of 4 or more on Chalder Fatigue Questionnaire scored bimodally (0,0,1,1)
Exclusion Criteria
1. Less than 18 years
2. Current or previous ME/CFS diagnosis
3. Current end-stage heart failure, cancer, sleep apnoea (or other major sleep disorders)
4. Major mental health diagnoses ( eg. schizophrenia)
5. Pregnant and lactating women
6. Care home residents
7. Dementia
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. The recruitment rate into our Phase 2 intervention will be recorded as the number of eligible participants who consented to participate in the study over the 4 month recruitment period.<br>2. The attrition rate in our Phase 2 intervention will be recorded as the number of eligible participants who consented to participate in the study but had not completed final 24 week follow-up measures.
- Secondary Outcome Measures
Name Time Method 1. Fatigue is measured using Chalder Fatigue Questionnaire (with participants completing online questionnaire using scoring 0,1,2,3) at 0, 12 and 24 weeks.<br>2. Physical functioning is measured using SF-12 at 0,12 and 24 weeks (online questionnaire) at 0, 12 and 24 weeks.<br>3. Quality of life is measured using EQ-5D at 0,12 and 24 weeks (online questionnaire) at 0, 12 and 24 weeks.